Compounded Tirzepatide

Tirzepatide is a once-weekly injectable medication that acts on both GLP-1 and GIP receptors to support appetite regulation, improve glycemic control, and promote clinically significant weight loss as part of a medically supervised treatment program.

Our 3-Month Starter Dose Package includes a three-month supply with gradual dose escalation, including 2.5 mg, 5 mg, and 7.5 mg, designed to support safe initiation and adjustment to treatment.

All first-time prescriptions require a telehealth consultation with a licensed M.D. Treatment is provided under the supervision of our medical team, including physicians and registered nurses, to ensure safe and appropriate care throughout your program.